Verilich hair serum in reducing hair shedding: A Case Report series
Abstract
Background: Hair shedding disorders, including Telogen Effluvium (TE) and Female Pattern Hair Loss (FPHL), are common dermatological concerns with limited effective treatment options. This case series evaluates the efficacy of Verilich hair serum in reducing hair shedding among female patients diagnosed with these conditions.
Methods: A clinical study was conducted on 20 female patients (aged 18–60) experiencing hair loss exceeding 80 strands per day. Patients underwent baseline assessments, including trichoscopic imaging, hair pull tests, and laboratory evaluations (thyroid profile, vitamin D, ferritin levels). Diagnoses were categorized based on hair diameter diversity, with TE defined by diversity <10% and FPHL by diversity >10%. Enrolled participants applied 1ml of Verilich serum twice daily for one month. Efficacy was measured by comparing pre- and post-treatment daily hair loss counts, with a ≥40% reduction considered a positive response.
Results: After one month of Verilich serum application, 75% of patients exhibited a significant reduction in hair shedding (≥40% reduction in daily hair count). Among TE patients, those with acute TE showed a higher response rate than those with chronic TE (CTE). Patients with FPHL also experienced substantial improvements in hair fall reduction. No adverse effects were reported during the study.
Conclusion: Verilich hair serum demonstrated significant efficacy in reducing hair shedding in both TE and FPHL patients. The formulation, containing anti-inflammatory, antioxidant, vasodilatory, and hair growth-promoting ingredients, effectively reduced active shedding and improved overall hair health. These findings support its potential as a safe and well-tolerated treatment for diffuse hair loss disorders.
Downloads
References
• Olsen, E. A. (2001). Female pattern hair loss. Journal of the American Academy of Dermatology, 45(3), S70-S80.
• Sinclair, R. (2015). Male pattern androgenetic alopecia. BMJ, 351, h3474.
• Whiting, D. A. (1996). Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. Journal of the American Academy of Dermatology, 35(6), 899-906.
• Malkud, S. (2015). Telogen effluvium: A review. Journal of Clinical and Diagnostic Research, 9(9), WE01-WE03.
• Kanti, V., Messenger, A., Dobos, G., Reygagne, P., Finner, A., Blumeyer, A., & Trüeb, R. M. (2018). The role of trichoscopy in the diagnosis and monitoring of alopecia: a review. Journal of the European Academy of Dermatology and Venereology, 32(5), 764-778.
• Trueb, R. M. (2009). Oxidative stress in ageing of hair. International Journal of Trichology, 1(1), 6-14.
• Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: a review. Drug Design, Development and Therapy, 13, 2777-2786.
